Felix Farma

Felix Farma is a Netherlands-based GMP manufacturer and specialist in the formulation of cannabis-based products for clinical research. Established in 2020 as a spin-off from the Transvaal Pharmacy (Transvaal Apotheek) in The Hague, the company operates in-house research and development, production, and quality control departments. Felix Farma produces standardized medicinal cannabis oils, such as Transvamix (THC 10% / CBD 5%), Transvaten, Transvabed, Transdica, and Transsati, as well as matching placebos for clinical trials. Its products are utilized in clinical studies investigating the therapeutic effects of cannabinoids on conditions such as epidermolysis bullosa-related pain and hepatocellular carcinoma. The company works closely with Bedrocan and the Dutch Office of Medicinal Cannabis (OMC) to source high-quality active pharmaceutical ingredients.